V

Varian

Tech-enabled radiation oncology hardware and software

Global Health Economics Director

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • An advanced degree in a health, business, or quantitative discipline with direct application to healthcare economics, finance, or outcomes measurement; alternatively, an MBA with 10+ years of progressive healthcare finance leadership within large, complex integrated delivery networks.
  • At least 8 years of progressive experience in strategic healthcare finance, health economics, or outcomes research, with director-level leadership scope, including ownership of multi-hundred-million-dollar profit and loss accounts, advising C-suite executives, and driving enterprise decision-making.
  • Expertise building sophisticated financial models for complex oncology programs, including cost-per-case analyses, return-on-investment and pro forma models, multi-scenario forecasting, budget impact frameworks, and service line economics. Proficiency in advanced Excel, business intelligence tools such as Power BI or Essbase, or equivalent tools, and data visualization.
  • Deep knowledge of U.S. healthcare economics and reimbursement, including Medicare and Medicaid, Centers for Medicare & Medicaid Services, commercial payers, hospital value analysis committees, and integrated delivery network procurement processes. Hands-on experience analyzing payer mix impact, reimbursement variability, and revenue optimization across clinical programs.
  • Strong understanding of oncology care pathways and the clinical and operational factors that drive financial performance, including radiation oncology economics such as linear accelerator utilization, fraction volume, and capital intensity; infusion economics; and specialty pharmacy.
  • A proven track record supporting large, complex strategic deals and partnerships with health-economic evidence and return-on-investment tools, including multi-year, multi-site program economics, capital investment justification, and performance modeling.
  • Ability to translate complex financial and clinical-economic data into clear, compelling narratives for CFO, CMO, COO, and CEO-level stakeholders, and influence strategic decisions without direct authority across matrixed organizations.
  • Experience partnering with clinical and operational leadership on strategic planning, including scenario-based planning, service line growth strategy, access expansion, and efficiency initiatives.
  • International healthcare economics experience and cross-cultural stakeholder engagement.

Responsibilities

  • Develop and lead the multi-year Cancer Care Value Programs strategic and financial roadmap, aligning it with corporate growth, profitability, and market expansion objectives.
  • Define, implement, and continuously refine a global key performance indicator framework to measure revenue growth and margin performance of Cancer Care Value Programs deals; customer value realization, including cost savings, throughput, and outcomes; market access milestones, including coverage, reimbursement levels, and policy wins; and adoption and utilization rates of oncology solutions.
  • Establish standardized dashboards and monthly, quarterly, and annual reporting cadence to track performance against key performance indicators and provide actionable insights to executive leadership.
  • Partner with Finance to integrate key performance indicators into budgeting, forecasting, and long-range planning processes, aligning strategic objectives and financial outcomes.
  • Lead performance reviews of Cancer Care Value Programs partnerships, identifying risks, opportunities, and corrective actions to optimize return on investment.
  • Build health-system-specific economic models and return-on-investment frameworks to support large-scale value partnership deals, including multi-year agreements with integrated delivery networks and government health authorities.
  • Design and oversee advanced health economic models, including cost-effectiveness analyses, budget impact models, cost-comparison and total cost of care analyses, and hospital-based health technology assessment models.
  • Define and track model performance key performance indicators, including forecast accuracy against realized outcomes and model adoption by commercial teams.
  • Translate modeling outputs into quantifiable performance metrics that can be tracked after implementation to validate value delivery.
  • Partner with Clinical Research and Medical Affairs to design real-world evidence and outcomes studies aligned to payer and health technology assessment expectations.
  • Define measurable clinical, operational, and economic endpoints and embed them into longitudinal key performance indicator tracking frameworks.
  • Develop and oversee processes to monitor real-world performance against projected value hypotheses, ensuring continuous feedback into strategy and modeling.
  • Develop value narratives, economic tools, and payer-facing materials for Cancer Care Value Programs solutions, including radiation therapy and theranostics.
  • Ensure value propositions are supported by clearly defined, trackable key performance indicators that resonate with stakeholders, such as cost per patient, improved outcomes, and system efficiency gains.
  • Partner with Global Commercial Marketing to integrate key-performance-indicator-driven value messaging into product launches and competitive positioning strategies.
  • Support reimbursement strategy and coding initiatives, including Current Procedural Terminology and Ambulatory Payment Classification codes, collaborating with Government Affairs on Centers for Medicare & Medicaid Services engagement and advocacy.
  • Define and monitor market access key performance indicators, including coverage decisions, reimbursement levels, and policy adoption timelines.
  • Track and report the financial and strategic impact of market access wins on Cancer Care Value Programs performance.
  • Collaborate with Digital Health and Artificial Intelligence teams to develop and validate outcomes evidence for artificial-intelligence-driven oncology solutions and workflow optimization tools.
  • Inform data-driven key performance indicator tracking systems leveraging digital tools and analytics platforms to provide real-time insights into performance.
  • Drive adoption of advanced analytics to enable predictive performance monitoring and continuous improvement of Cancer Care Value Programs offerings.
  • Serve as a strategic partner across functions, ensuring alignment on goals, metrics, and performance tracking.
  • Lead governance forums to review key performance indicators, assess progress, and drive decision-making across global stakeholders.
  • Build a culture of data-driven accountability and performance management within the Cancer Care Value Programs organization.

About the Company

Varian

Tech-enabled radiation oncology hardware and software

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Palo Alto, CA
Founded
1948

Recently Posted Jobs

Explore more opportunities at Varian

See more jobs